SCHMID Group N.V. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing covers the month of July 2026 for SCHMID Group N.V., a foreign private issuer. The report details two material events occurring on July 7, 2026: the entry into a definitive agreement for a $20 million convertible notes financing and the receipt of a significant repeat order for advanced manufacturing equipment.
Key Financial Metrics and Capital Structure
- Financing: The Company agreed to issue senior convertible notes with an aggregate principal amount of $20.0 million.
- Note Terms: Issued at 99% of principal; 5% annual interest compounded quarterly (payable in kind or cash at Company's election); maturity date of January 14, 2029.
- Conversion Terms: Convertible at the lower of $10.50 or 97% of the applicable volume-weighted average price, subject to a minimum conversion price of $1.93 per share.
- Order Intake: For the six months ended June 30, 2026, order intake was EUR 44.3 million excluding the new order, and EUR 81.7 million including the new order.
- Share Count: As of July 7, 2026, outstanding ordinary shares totaled 65,675,726. This includes 1,490,000 shares issued under the Standby Equity Purchase Agreement (SEPA).
Material Changes and New Developments
- Large Order Receipt: The Company secured a repeat order exceeding EUR 37 million from a major customer for advanced mSAP production equipment. This equipment supports AI server board and optical module applications and follows a successful initial project in 2025.
- Capital Deployment: Net proceeds from the $20 million notes will fund working capital needs driven by order intake acceleration and growth capital for transitioning from a rented to an owned manufacturing plant in China, which will nearly double capacity.
- Guarantees: Obligations under the notes are guaranteed by the German operating subsidiary, Gebr. Schmid GmbH, subject to applicable German law limitations.
Guidance, Outlook, and Risks
- Guidance Revision: Due to accelerated order intake, the Company is reviewing an upward revision of its full-year 2026 order intake guidance. Revised quantitative guidance is expected to be communicated on or about July 14, 2026.
- Registration Rights: The Company agreed to file a registration statement covering the resale of shares issuable upon conversion of the notes.
- Risks and Uncertainties: The filing includes standard forward-looking statement disclaimers. Specific risks mentioned include the timing of plans to regain compliance with Nasdaq requirements, potential inability to meet those requirements, and delays in securing financing.
Investor Verification Checklist
- Verify the final terms of the Investment Agreement (Exhibit 10.1) regarding conversion limits and covenants.
- Monitor the July 14, 2026 business update for the revised full-year 2026 order intake guidance.
- Confirm the status of the Company's compliance plan with Nasdaq and any extensions granted.
- Review the registration statement for the resale of shares upon conversion of the notes.
- Assess the impact of the EUR 37 million order on the Company's revenue recognition timeline and gross margins.